en
Scientific article
English

Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non–Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation : Phase II Trial SAKK19/09

Published inClinical lung cancer, vol. 16, no. 5, p. 358-365
Publication date2015-09
Keywords
  • Bevacizumab
  • Chemotherapy
  • Erlotinib
  • Lung cancer
  • Pemetrexed
Citation (ISO format)
GAUTSCHI, Oliver et al. Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non–Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation : Phase II Trial SAKK19/09. In: Clinical lung cancer, 2015, vol. 16, n° 5, p. 358–365. doi: 10.1016/j.cllc.2015.02.007
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1525-7304
12views
0downloads

Technical informations

Creation12/06/2023 3:17:43 PM
First validation03/20/2024 10:35:29 AM
Update time03/20/2024 10:35:29 AM
Status update03/20/2024 10:35:29 AM
Last indexation03/20/2024 10:35:49 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack